Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 May 15;15(10):2762. doi: 10.3390/cancers15102762

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Dose distribution of (a) BNCT and (b) IMRT and MRI (c) before and (d) 6 months after combined treatment for recurrent mucoepidermoid carcinoma of the right parotid gland. The color wash in (a) showed the BNCT dose level represented by a spectrum from the blue to the red (3.8 to 38.0 Gy-Eq, respectively). The color wash in (b) showed the area covered by 45 Gy and above with IMRT. The mean dose of BNCT was 25.4 Gy-Eq in a single fraction, and the prescription dose of IMRT was 45 Gy/25 fractions. The tumor decreased in size significantly after therapy.